The Centers for Disease Control and Prevention (CDC) has released updated interim clinical guidance for healthcare providers evaluating infants born to mothers with possible Zika virus exposure during pregnancy. Published following an expert meeting convened with the American Academy of Pediatrics (AAP), the revised framework modifies initial screening protocols, outpatient monitoring, and multidisciplinary care strategies for congenital exposure.
In Plain English: The Clinical Takeaway
Cranial Ultrasounds Required: Infants now need a cranial ultrasound (imaging of the brain using sound waves) even if prenatal scans during the third trimester appeared normal.
Comprehensive Outpatient Tracking: Care through the first year includes repeat eye and hearing tests, plus hormonal (endocrine) evaluations.
Coordinated Medical Homes: Affected families require a centralized multidisciplinary care team rather than isolated specialist visits.
Refining Infant Evaluation Protocols and Diagnostic Nuances
The updated guidance, issued by federal health authorities on August 19, 2016, shifts away from previous recommendations by removing dengue virus testing protocols and advising clinicians against testing cord blood specimens. According to the CDC, the new framework directly addresses how infant laboratory results should be interpreted.
Most notably, the revised guidelines alter diagnostic thresholds for neonatal brain imaging. While previous recommendations permitted clinicians to skip postnatal cranial ultrasounds if prenatal ultrasound results from the third trimester demonstrated no abnormalities of the brain, the updated directive recommends a cranial ultrasound regardless of prior prenatal scan results. This change accounts for the limits of prenatal sensitivity, where subtle neuropathology—such as ventriculomegaly or early microcephaly—can evade detection depending on maternal factors (e.g., obesity), gestational age, and equipment constraints.
Expanding Outpatient Management Through the First Year
Beyond the neonatal ward, the framework addresses long-term developmental trajectories. Earlier guidelines limited post-discharge recommendations to considering an additional hearing screen at six months alongside evaluating head circumference and developmental milestones throughout the first year of life. The updated 2016 guidance provides additional recommendations for the outpatient management of infants through the first year of life.
Clinicians must now integrate repeat audiological and ophthalmological assessments to monitor progressive or late-onset sensory deficits. Furthermore, the updated recommendations introduce endocrine evaluations to monitor hormonal development, reflecting the broader systemic impact of congenital Zika syndrome. To manage these complex needs, the CDC recommends establishing a formal “medical home”—a centralized model of primary care that facilitates coordinated intervention across pediatric subspecialties.
| Clinical Parameter | Previous Guidance (February) | Updated Guidance (August) |
|---|---|---|
| Cranial Ultrasound | Optional if third-trimester prenatal scan was normal. | Recommended even if the prenatal ultrasound was normal. |
| Laboratory Testing | Included dengue testing and cord blood specimen analysis. | Excludes dengue testing; recommends against cord blood testing. |
| Specialist Evaluations | Consider hearing screen at 6 months; track milestones. | Repeat eye, hearing, and new endocrine evaluations. |
| Care Coordination | Standard pediatric follow-up. | Multidisciplinary care team and established medical home. |
Geopolitical and Public Health Integration
Jurisdictions can now utilize a planning resource created by the Department of Health and Human Services (HHS) to support their preparedness and response activities concerning services and supports for children with special health care needs.
Contraindications & When to Consult a Doctor
Healthcare providers must carefully review diagnostic limitations before ordering invasive procedures. For instance, amniocentesis—sometimes considered during pregnancy to detect viral RNA via nucleic acid amplification tests (NAAT)—is not recommended until after 15 weeks of gestation because amniocentesis performed at ≥15 weeks of gestation is associated with lower rates of complications than when performed at earlier gestational ages. Clinicians must weigh the transient nature of viral RNA in amniotic fluid against the diagnostic yield.
Early identification through the designated medical home remains critical for optimizing developmental outcomes.
References
- Centers for Disease Control and Prevention. (2016). CDC updates guidance for care of infants born to mothers with possible Zika virus infection during pregnancy. Media Statement.
- Centers for Disease Control and Prevention. (2016). Clinical considerations for pregnant women with possible Zika virus infection. Morbidity and Mortality Weekly Report (MMWR), 65(33).
